Presentation Information
[SY-52-04]Current Updates and Innovations in ADHD
*Ahsan Nazeer (Weill Cornell, NY, USA/ Sidra Medicine, Qatar(Qatar))
Keywords:
ADHD,EndeavorRx,Viloxazine,Child and Adolescent Psychiatry,Adverse Childhood Experiences (ACEs)
Recent advancements in ADHD include new medication options, digital therapies, and deeper insights into the disorder's complexities. These include newer non-stimulant drugs like Viloxazine extended release and the first transdermal amphetamine patch, offering more personalized treatment choices. Digital therapies such as EndeavorRx, a video game-based approach, and the Monarch eTNS System are increasingly popular. Additionally, research is examining how ADHD exists on a spectrum with varying symptom severity along with the role of ACEs.